About QuidelOrtho Corporation - Common Stock (QDEL)
QuidelOrtho Corp is a prominent player in the field of medical diagnostics, specializing in the development and manufacture of diagnostic testing solutions. The company focuses on producing innovative products that aid in the rapid detection of infectious diseases and other critical health conditions, utilizing advanced technologies such as molecular diagnostics and immunoassay platforms. QuidelOrtho's portfolio includes a range of tests designed for use in various healthcare settings, including hospitals, laboratories, and physician offices, facilitating timely and accurate diagnoses that enhance patient care. Through its commitment to innovation and quality, the company strives to improve the health outcomes of individuals around the globe. Read More
Check out the companies making headlines yesterday: AppLovin (NASDAQ:APP): Mobile app technology company AppLovin (NASDAQ:APP) rose by 3.8% on Monday after R...
What Happened? Shares of healthcare diagnostics company QuidelOrtho (NASDAQ:QDEL) jumped 34.7% in the afternoon session after reports revealed that the compa...
Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that ...
Unprofitable companies can burn through cash quickly, leaving investors exposed if they fail to turn things around. Without a clear path to profitability, th...
Small-cap stocks in the Russell 2000 (^RUT) can be a goldmine for investors looking beyond the usual large-cap names. But with less stability and fewer resou...
The low valuation multiples for value stocks provide a margin of safety that growth stocks rarely offer. However, the challenge lies in determining whether t...
The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk tha...
QuidelOrtho’s first quarter was marked by notable headwinds, as management pointed to a significantly milder and shorter respiratory illness season compared ...
Healthcare diagnostics company QuidelOrtho (NASDAQ:QDEL) fell short of the market’s revenue expectations in Q1 CY2026, with sales falling 10.5% year on year ...
Healthcare diagnostics company QuidelOrtho (NASDAQ:QDEL) missed Wall Street’s revenue expectations in Q1 CY2026, with sales falling 10.5% year on year to $61...
Healthcare diagnostics company QuidelOrtho (NASDAQ:QDEL) will be reporting earnings this Tuesday after market hours. Here’s what you need to know. QuidelOrth...
The past year hasn't been kind to the stocks featured in this article. Each has tumbled to their lowest points in 12 months, leaving investors to decide whet...
The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk tha...
What Happened? A number of stocks fell in the afternoon session after a proposed 2027 federal budget revealed significant spending cuts for key health agenci...
Personal health and wellness is one of the many secular tailwinds for healthcare companies. But speed bumps such as inventory destockings have persisted in t...
What Happened? A number of stocks fell in the afternoon session after major indices including the S&P 500 and Dow Jones Industrial Average fell sharply as in...
